Q32 Bio Inc. (QTTB) Net Cash Flow (2017 - 2026)

Q32 Bio has reported Net Cash Flow for 10 years, with the latest figure at $55.5 million in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 621.26% year-over-year to $55.5 million in Q2 2026; TTM through Jun 2026 was $51.4 million, a 220.1% increase from a year earlier, with the FY2025 full-year figure at -$29.7 million, down 162.66% from the prior year.
• Net Cash Flow was $55.5 million for Q2 2026 at Q32 Bio, up from $2.5 million in the prior quarter.
• The five-year high for Net Cash Flow was $138.1 million in Q1 2022, with the low at -$133.0 million in Q3 2022.
• Average Net Cash Flow over 5 years is -$1.1 million, with a median of -$9.9 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow tumbled 707.0% in 2022, then soared 779.9% in 2024.
• Over 5 years, Net Cash Flow stood at -$9.2 million in 2022, then declined by 15.94% to -$10.6 million in 2023, then retreated by 4.46% to -$11.1 million in 2024, then jumped by 93.32% to -$742000.0 in 2025, then jumped by 7582.35% to $55.5 million in 2026.
• The last three Net Cash Flow figures came in at $55.5 million (Q2 2026), $2.5 million (Q1 2026), and -$742000.0 (Q4 2025), per Business Quant data.